AbbVie | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
AbbVie USD 1.66B 3.15B 2025-03
Abbott USD 2.15B 372M 2025-06
ALKERMES USD 104.84M 79.35M 2025-06
Amgen USD 1.57B 405M 2025-06
AstraZeneca USD 3.13B 275M 2025-06
Biogen USD 744M 432.8M 2025-06
BioMarin Pharmaceutical USD 297.87M 59.78M 2025-06
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
Eisai JPY 22.4B 22.43B 2025-06
Eli Lilly USD 6.78B 3.32B 2025-06
Gilead Sciences USD 2.43B 780M 2025-06
GlaxoSmithKline GBP 1.89B 221M 2025-06
J&J USD 13.63B 8.21B 2025-03
Medtronic USD 1.87B 612M 2025-07
Merck USD 6.77B 864M 2025-06
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
Novartis USD 4.53B 124M 2025-06
Pacira USD -1927000 10.63M 2025-06
Perrigo USD 3.2M 5.1M 2025-06
Pfizer USD 3.04B 259M 2025-06
Regeneron Pharmaceuticals USD 1.52B 613.7M 2025-06
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 1.42B 734M 2025-06
UCB EUR 1.22B 781M 2024-12
Ultragenyx Pharmaceutical USD -114004000 35.77M 2025-06
United Therapeutics USD 408.4M 15.1M 2025-06
Vertex Pharmaceuticals USD 1.28B 552.6M 2025-06
Zoetis USD 902M 92M 2025-06


AbbVie L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.